ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma

Summary: Sorafenib induces ferroptosis, making it a useful treatment against advanced liver hepatocellular carcinoma (LIHC). However, sorafenib resistance is extremely common among LIHC patients. Here, we used a comprehensive approach to investigate the effects of ABHD12, which regulates tumorigenes...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mengxing Cai, Jingwen Luo, Chunxiu Yang, Xiaopeng Yang, Cheng Zhang, Lixin Ma, Yibin Cheng
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2023-12-01
Serija:	iScience
Teme:	Pharmacology Natural sciences Biological sciences Systems biology Cancer systems biology Cancer
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2589004223024173
Oznake:	Označite Brez oznak, prvi označite!